Trial Profile
A randomised phase II trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 27 Oct 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 30 Apr 2013 New trial record